Is there a role for radiotherapy in the management of upper gastrointestinal malignancies?
Radiation therapy has several established roles in the management of upper gastrointestinal malignancy. These roles parallel those for which radiation is used in other anatomic regions (e.g., single and multimodality management with curative intent, organ preservation, and palliation). This article provides a brief summary of the use of radiotherapy in the management of upper gastrointestinal malignancies. It includes applications for radiotherapy used with curative and palliative intent.
Abrams
R A
RA
Departments of Oncology and Radiologic Sciences, Johns Hopkins Oncology Center, Baltimore, MD 21287, USA.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000532:radiotherapy; D018281:Cholangiocarcinoma / Q000532:radiotherapy; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000532:radiotherapy; D005770:Gastrointestinal Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D006801:Humans; D008113:Liver Neoplasms / Q000532:radiotherapy; D020360:Neoadjuvant Therapy; D010166:Palliative Care; D010190:Pancreatic Neoplasms / Q000532:radiotherapy; D018714:Radiotherapy, Adjuvant
D000970:Antineoplastic Agents